Close
  Indian J Med Microbiol
 

Figure 2 A comparison of histamine levels at the sixth month (a) between chronic myeloid leukemia (CML) patients who achieved and did not achieve complete hematological response (CHR) (P = 0.043), (b) between CML patients with complete cytogenetic response (CCgR), partial cytogenetic response (PCgR), minor cytogenetic response (mCgR), minimal cytogenetic response (minCgR), and no cytogenetic response (noCgR) (P = 0.021), and (c) between CML patients with major molecular response (MMolR) and no molecular response (P = 0.006).

Figure 2 A comparison of histamine levels at the sixth month (a) between chronic myeloid leukemia (CML) patients who achieved and did not achieve complete hematological response (CHR) (<i>P</i> = 0.043), (b) between CML patients with complete cytogenetic response (CCgR), partial cytogenetic response (PCgR), minor cytogenetic response (mCgR), minimal cytogenetic response (minCgR), and no cytogenetic response (noCgR) (<i>P</i> = 0.021), and (c) between CML patients with major molecular response (MMolR) and no molecular response (<i>P</i> = 0.006).